Expression of the NOB1 gene and its clinical significance in papillary thyroid carcinoma

Journal of International Medical Research

Volumn 41, Issue 3, 2013, Pages 568-572

  Lin, Shan ^a   Meng, Wei ^a   Zhang, Wei ^a   Liu, Jia ^a   Wang, Peisong ^a   Xue, Shuai ^a   Chen, Guang ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

clinical significance; immunohistochemistry; NOB1; Papillary thyroid carcinoma; quantitative RT PCR

Indexed keywords

BINDING PROTEIN; MESSENGER RNA; NOB1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; CANCER STAGING; CARCINOGENESIS; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLUORESCENCE ANALYSIS; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NOB1 GENE; NODULAR GOITER; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; THYROID ADENOMA; THYROID PAPILLARY CARCINOMA; THYROID TUMOR; THYROIDECTOMY; TUMOR VOLUME;

CLINICAL SIGNIFICANCE; IMMUNOHISTOCHEMISTRY; NOB1; PAPILLARY THYROID CARCINOMA; QUANTITATIVE RT-PCR;

ADULT; CARCINOMA; FEMALE; GENE EXPRESSION; GOITER, NODULAR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; NUCLEAR PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEINS; THYROID GLAND; THYROID NEOPLASMS; TUMOR BURDEN;

EID: 84887380976     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060513479862     Document Type: Article

References (15)

1. Brown RL,de Souza JA.Thyroid cancer: burden of illness and management of disease.J Cancer. 2012;2:193-199.
2. Guang C,Meishan J,Shan L.Increased expression cysteine-rich61 (Cyr61) in patients with thyroid carcinomas.Afr J Pharm Pharmacol. 2011;5:2517-2521.
3. Ito Y,Yoshida H,Tomoda C,et al.Expression of S100A2 and S100A6 in thyroid carcinoma.Histopathology. 2005;46:569-575.
4. Roskies M,Dolev Y,Caglar D,et al.Vitamin D deficiency as a potentially modifiable risk factor for thyroid cancer.J Otolaryngol Head Neck Surg. 2012;41:160-163.
5. Dal Maso L,Bosetti C,La Vecchia C,et al.Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors.Cancer Causes Control. 2009;20:75-86.
6. Nikiforov YE,Biddinger PW,Thompson LDiagnostic pathology and molecular genetics of the thyroid. 1st ed. Baltimore, MD: Lippincott, Williams and Wilkins, 2009.Baltimore, MD: Lippincott, Williams and Wilkins; 2009:.
7. Lamanna AC,Karbstein K.Nob1 binds the single-stranded cleavage site D at the 3′-end of 18S rRNA with its PIN domain.Proc Natl Acad Sci U S A. 2009;106:14259-14264.
8. Zhang Y,Ni J,Zhou G,et al.Cloning, expression and characterization of the human NOB1 gene.Mol Biol Rep. 2005;32:185-189.
9. Vivan GO,Ka YY,Yongjae GG,et al.The derivation of diagnostic markers of chronic myeloid leukemia progression from microarray data.Blood. 2009;114:3292-3298.
10. Lu Z,Guo Q,Shi A,et al.Down regulation of NIN/RPN12 binding protein inhibit the growth of human hepatocellular carcinoma cells.Mol Biol Rep. 2012;39:501-507.
11. Rosai J,Carcangiu ML,Delellis RATumors of the thyroid gland. Atlas of tumor pathology, Third series, Fascicle 5. Washington, DC: Armed Forces Institute of Pathology; 1992:.
12. Campo E,Merino MJ,Liotta L,et al.Distribution of 72KD type IV collagenase in nonneoplastic and neoplastic thyroid tissue.Hum Pathol. 1992;23:1395-1401.
13. Huang WY,Chen DH,Ning L,et al.siRNA mediated silencing of NIN1/RPN12 binding protein 1 homolog inhibits proliferation and growth of breast cancer cells.Asian Pac J Cancer Prev. 2012;13:1823-1827.
14. Wu DP,He XW.Expression of NOB1 and its significance in colorectal cancer.J South Med Univ. 2012;32:420-422.
15. Lin Y,Peng S,Yu H,et al.RNAi-mediated downregulation of NOB1 suppresses the growth and colony-formation ability of human ovarian cancer cells.Med Oncol. 2012;29:311-317.